Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: Qiang, Min | Xiao, Rong | Su, Tao | Wu, Bei-Bei | Tong, Zhi-Qian | Liu, Ying | He, Rong-Qiao
Article Type: Research Article
Abstract: Alzheimer's disease (AD) is the most common form of dementia, affecting millions of people worldwide. Increasing evidence suggests that formaldehyde might be one of the various pathological mechanisms involved in the process of AD onset. Here, we use an AD mouse model, senescence accelerated mouse-prone 8 strain (SAMP8), to study the relationship between endogenous formaldehyde and impairment of cognition. The Morris water maze test was used to evaluate the spatial learning and memory ability of 3-month-old SAMP8 mice, and we correlated the results with endogenous formaldehyde concentrations in the brain. To investigate the underlying reasons for formaldehyde elevation in neurodegenerative …diseases, the expression levels of enzymes involved in formaldehyde metabolism were analyzed, including (anabolic) semicarbazide sensitive amine oxidase (SSAO) and (catabolic) alcohol dehydrogenase III (ADH3). When compared with age-matched SAMR1 mice, we found that in 3-month-old SAMP8 mice the capacity for spatial learning and memory was lower, while brain formaldehyde levels were higher. By using real-time PCR, western blotting, enzyme assay, and immunohistochemistry techniques, we discovered that SSAO expression levels were increased, whereas ADH3 exhibited reduced expression levels of mRNA, protein, and enzyme activity. The imbalance of these metabolic enzymes may represent a causal explanation for the observed formaldehyde elevation in the SAMP8 brain. Such increase could be responsible for the observed tau hyperphosphorylation assumed to result in protein aggregation, ultimately leading to cognitive impairment. Taken together, our study gives new insights into the role of metabolic enzymes in age-related accumulation of formaldehyde, and thus the establishment of neurodegenerative diseases. Show more
Keywords: Alzheimer's disease, enzymes, formaldehyde, metabolism, SAMP8, SAMR1, SSAO, ADH3
DOI: 10.3233/JAD-131595
Citation: Journal of Alzheimer's Disease, vol. 40, no. 4, pp. 1039-1053, 2014
Authors: Zimmermann, Ruediger | Huber, Ellen | Schamber, Christine | Lelental, Natalia | Mroczko, Barbara | Brandner, Sebastian | Maler, Juan Manuel | Oberstein, Timo | Szmitkowski, Maciej | Rauh, Manfred | Kornhuber, Johannes | Lewczuk, Piotr
Article Type: Research Article
Abstract: Changes in the concentrations of amyloid-β (Aβ) in the body fluids are the earliest alterations observed in Alzheimer's disease (AD), however, there is a lack of data about how early these alterations occur, before the onset of the clinical symptoms. APOE genotype is the most recognized genetic risk/protective factor of AD, meaning that a group of non-demented persons carrying ε4 allele is enriched in the subjects who will develop AD, compared to the group of non-carriers. Therefore, we studied the plasma concentrations of Aβ peptides (Aβ1-42 , Aβ1-40 , Aβx-42 , and Aβx-40 ), and the APOE genotype in 173 …young volunteers (average age, 28 ± 7.6 years) without memory deficits, in order to see whether the non-demented group of subjects at risk already characterize with Aβ changes three-to-four decades before the age at which dementia usually occurs. We did not find statistically significant differences among the groups of ε4 carriers, ε3 homozygotes, and ε2 carriers. We conclude that the APOE genotype does not influence the metabolism of the Aβ peptides in young persons without memory deficits. Show more
Keywords: Amyloid-β, APOE genotype, blood biomarkers, non-demented volunteers
DOI: 10.3233/JAD-132687
Citation: Journal of Alzheimer's Disease, vol. 40, no. 4, pp. 1055-1060, 2014
Authors: George, Daniel R. | D'Alton, Simon
Article Type: Review Article
DOI: 10.3233/JAD-140707
Citation: Journal of Alzheimer's Disease, vol. 40, no. 4, pp. 1061-1062, 2014
Article Type: Correction
DOI: 10.3233/JAD-149003
Citation: Journal of Alzheimer's Disease, vol. 40, no. 4, pp. 1063-1063, 2014
Article Type: Other
DOI: 10.3233/JAD-132688
Citation: Journal of Alzheimer's Disease, vol. 40, no. 4, pp. 1065-1067, 2014
Article Type: Other
DOI: 10.3233/JAD-2014-40426
Citation: Journal of Alzheimer's Disease, vol. 40, no. 4, pp. 1069-1080, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl